References
- Kyari F, Tafida A, Sivasubramaniam S, Murthy GV, Peto T, Gilbert CE. Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Public Health. 2014;14(1):1299. doi:https://doi.org/10.1186/1471-2458-14-1299.
- Wang Y, Yuan Y, Jiang H. Serum and vitreous levels of visfatin in patients with diabetic retinopathy. Med Sci Monit. 2014;20:2729–2732. doi:https://doi.org/10.12659/MSM.891292.
- Vujosevic S, Pucci P, Casciano M, Daniele A, Bini S, Berton M, Cavarzeran F, Avogaro A, Lapolla A, Midena E. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy. J Diabetes Complications. 2017;31(8):1348–1353. doi:https://doi.org/10.1016/j.jdiacomp.2017.04.010.
- Lewis AD, Hogg RE, Chandran M, Musonda L, North L, Chakravarthy U, Sivaprasad S, Menon G. Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study. Eye. 2018;32(7):1201–1208. doi:https://doi.org/10.1038/s41433-018-0055-x.
- El-Bab MF, Shawky N, Al-Sisi A, Akhtar M. Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia. Clin Ophthalmol. 2012;6:269–276. doi:https://doi.org/10.2147/OPTH.S27363.
- Martinez B, Peplow PV. MicroRNAs as biomarkers of diabetic retinopathy and disease progression. Neural Regen Res. 2019;14(11):1858–1869. doi:https://doi.org/10.4103/1673-5374.259602.
- Gomaa AR, Elsayed ET, Moftah RF. MicroRNA-200b expression in the vitreous humor of patients with proliferative diabetic retinopathy. Ophthalmic Res. 2017;58(3):168–175. doi:https://doi.org/10.1159/000475671.
- Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2011;52(7):4402–4409. doi:https://doi.org/10.1167/iovs.10-6879.
- Zhang C, Qian D, Zhao H, Lv N, Yu P, Sun Z. MiR17 improves insulin sensitivity through inhibiting expression of ASK1 and anti-inflammation of macrophages. Biomed Pharmacother. 2018;100:448–454. doi:https://doi.org/10.1016/j.biopha.2018.02.012.
- Ling S, Birnbaum Y, Nanhwan MK, Thomas B, Bajaj M, Ye Y. 2013. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina. Cell Signal. 25(12):2840–2847. doi:https://doi.org/10.1016/j.cellsig.2013.08.039.
- Chen Q, Qiu F, Zhou K, Matlock HG, Takahashi Y, Rajala R, Yang Y, Moran E, Ma JX. 2017. Pathogenic role of microRNA-21 in diabetic retinopathy through downregulation of PPARα. Diabetes. 66(6):1671–1682. doi:https://doi.org/10.2337/db16-1246.
- McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes. 2011;60(4):1314–1323. doi:https://doi.org/10.2337/db10-1557.
- Syafruddin SE, Mohtar MA, Wan Mohamad Nazarie WF, Low TY. Two sides of the same coin: the roles of KLF6 in physiology and pathophysiology. Biomolecules. 2020;10(10):1378. doi:https://doi.org/10.3390/biom10101378.
- Villani R, Magnati GP, Girolamo Sangineto DG, Romano M, Cassano AD, Serviddio T. Genetic polymorphisms and clinical features in diabetic patients with fatty liver: results from a single-center experience in Southern Italy. Front Med. 2021;8:737759. doi:https://doi.org/10.3389/fmed.2021.737759.
- Liang X, Xu W. miR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6. Exp Ther Med. 2020;20(2):1121–1128. doi:https://doi.org/10.3892/etm.2020.8780.
- Wu JH, Wang YH, Wang W, Shen W, Sang YZ, Liu L, Chen CM. MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways. Int J Biochem Cell Biol. 2016;73:41–52. doi:https://doi.org/10.1016/j.biocel.2016.02.002.
- Tian J, Ma H, Luo Y, Hu A, Lin S, Li T, Guo K, Li J, Cai M, Tang S. The influence of high glucose on the Cip/Kip family expression profiles in HRECs. J Mol Histol. 2013;44(6):705–713. doi:https://doi.org/10.1007/s10735-013-9510-y.
- Xu XH, Zhao C, Peng Q, Xie P, Liu QH. Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment. Braz J Med Biol Res. 2017;50(3):e5396. doi:https://doi.org/10.1590/1414-431X20165396.
- Ibrahim AS, Elshafey S, Sellak H, Hussein KA, El-Sherbiny M, Abdelsaid M, Rizk N, Beasley S, Tawfik AM, Smith SB, et al. A lipidomic screen of hyperglycemia-treated HRECs links 12/15-lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase. J Lipid Res. 2015;56(3):599–611. doi:https://doi.org/10.1194/jlr.M056069.
- Wu Y, Zhang Q, Zhang R. Kaempferol targets estrogen-related receptor alpha and suppresses the angiogenesis of human retinal endothelial cells under high glucose conditions. Exp Ther Med. 2017;14(6):5576–5582.
- Yang WZ, Yang J, Xue LP, Xiao LB, Li Y. MiR-126 overexpression inhibits high glucose-induced migration and tube formation of rhesus macaque choroid-retinal endothelial cells by obstructing VEGFA and PIK3R2. J Diabetes Complications. 2017;31(4):653–663. doi:https://doi.org/10.1016/j.jdiacomp.2016.12.004.
- Nigro C, Mirra P, Prevenzano I, Leone A, Fiory F, Longo M, Cabaro S, Oriente F, Beguinot F, Miele C. miR-214-dependent increase of PHLPP2 levels mediates the impairment of insulin-stimulated Akt activation in mouse aortic endothelial cells exposed to methylglyoxal. Int J Mol Sci. 2018;19.
- Martinez-Micaelo N, Beltran-Debon R, Baiges I, Faiges M, Alegret JM. Specific circulating microRNA signature of bicuspid aortic valve disease. J Transl Med. 2017;15(1):76. doi:https://doi.org/10.1186/s12967-017-1176-x.
- Gao Y, Xu Z, Yuan F, Li M. Correlation of expression levels of micro ribonucleic Ccid-10b (miR-10b) and micro ribonucleic acid-181b (miR-181b) with gastric cancer and its diagnostic significance. Med Sci Monit. 2018;24:7988–7995. doi:https://doi.org/10.12659/MSM.910809.
- Liu HN, Qie P, Yang G, Song YB. miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2. Arch Med Sci. 2018;14(4):745–751.
- Zhang Y, Li C, Guan C, Zhou B, Wang L, Yang C, Zhen L, Dai J, Zhao L, Jiang W, et al. MiR-181d-5p targets KLF6 to improve ischemia/reperfusion-induced AKI through effects on renal function. Front Physiol. 2020;11:510.
- Xu W, Zhang H, Zhang Q, Xu J. beta-Amyrin ameliorates diabetic nephropathy in mice and regulates the miR-181b-5p/HMGB2 axis in high glucose-stimulated HK-2 cells. Environ Toxicol. 2021.
- Atkins GB, Jain MK. Role of Kruppel-like transcription factors in endothelial biology. Circ Res. 2007;100(12):1686–1695. doi:https://doi.org/10.1161/01.RES.0000267856.00713.0a.
- Gao P, Meng XF, Su H, He FF, Chen S, Tang H, Tian XJ, Fan D, Wang YM, Liu JS, et al. Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy. Biochim Biophys Acta. 2014;1843(11):2448–2460. doi:https://doi.org/10.1016/j.bbamcr.2014.07.001.
- Qi W, Chen X, Holian J, Tan CY, Kelly DJ, Pollock CA. Transcription factors Krüppel-like factor 6 and peroxisome proliferator-activated receptor-{gamma} mediate high glucose-induced thioredoxin-interacting protein. Am J Pathol. 2009;175(5):1858–1867. doi:https://doi.org/10.2353/ajpath.2009.090263.
- Qi W, Holian J, Tan CY, Kelly DJ, Chen XM, Pollock CA. 2011. The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-γ in the regulation of macrophage inflammatory protein-3α at early onset of diabetes. Int J Biochem Cell Biol. 43(3):383–392. doi:https://doi.org/10.1016/j.biocel.2010.11.008.